减毒温度敏感甲型流感病毒（H3N2）未能在人类中诱导对1型副流感病毒的异源干扰。
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus.
作者信息
Murphy B R, Richman D D, Chalhub E G, Uhlendorf C P, Baron S, Chanock R M
出版信息
Infect Immun. 1975 Jul;12(1):62-8. doi: 10.1128/iai.12.1.62-68.1975.
Abstract
The present investigation was undertaken to determine if a candidate live vaccine virus, influenza A/Hong Kong/68-ts-1 [E] (H3N2), induced heterologous interference against an interferon-sensitive, wild-type, parainfluenza type 1 challenge virus. The parainfluenza virus was administered 7 days after Hong Kong/68-ts-1 [E] virus infection. The clinical response, daily quantitative virus shedding, interferon production, and serum and nasal wash antibody responses were determined in an experimental group (influenza A virus followed by parainfluenza virus) and 10 volunteers in a control group (parainfluenza virus only). The volunteers were selected on the basis of susceptibility to the two viruses, i.e. serum hemagglutination-inhibition antibody titer of is less than or greater to 1:8 for influenza virus and low nasal wash antibody titer (is less than or greater to 1:8) for parainfluenza virus. Despite a 100% infection rate in the Hong Kong/68-ts-1 [E] vaccinees, no heterologous interference was induced against the parainfluenza type 1 virus challenge.
摘要
本研究旨在确定候选活疫苗病毒甲型流感/香港/68-ts-1 [E]（H3N2）是否能诱导对干扰素敏感的野生型1型副流感攻击病毒产生异源干扰。在香港/68-ts-1 [E]病毒感染7天后接种副流感病毒。在一个实验组（先接种甲型流感病毒，后接种副流感病毒）和10名对照组志愿者（仅接种副流感病毒）中测定了临床反应、每日定量病毒排出量、干扰素产生以及血清和鼻腔冲洗液抗体反应。志愿者是根据对这两种病毒的易感性挑选的，即甲型流感病毒的血清血凝抑制抗体效价小于或大于1:8，1型副流感病毒的鼻腔冲洗液抗体效价低（小于或大于1:8）。尽管接种香港/68-ts-1 [E]疫苗的人感染率为100%，但未诱导出对1型副流感病毒攻击的异源干扰。
相似文献
1
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus.
Infect Immun. 1975 Jul;12(1):62-8. doi: 10.1128/iai.12.1.62-68.1975.
2
Enzyme-linked immunosorbent assay for detection of antibodies to influenza A and B and parainfluenza type 1 in sera of patients.
J Clin Microbiol. 1978 Dec;8(6):648-56. doi: 10.1128/jcm.8.6.648-656.1978.
3
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.
J Pediatr. 1978 Jul;93(1):28-32. doi: 10.1016/s0022-3476(78)80594-0.
4
Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
J Infect Dis. 1976 Jun;133(6):613-20. doi: 10.1093/infdis/133.6.613.
5
Evidence of prior infection with influenza A/Texas/77 (H3N2( virus in dogs with clinical parainfluenza.
Can J Comp Med. 1980 Oct;44(4):396-402.
6
Temperature-sensitive mutants of influenza A virus: response of children to the influenza A/Hong Kong/68-ts-1(E) (H3N2) and influenza A/Udorn/72-ts-1(E) (H3N2) candidate vaccine viruses and significance of immunity to neuraminidase antigen.
Pediatr Res. 1976 Apr;10(4):238-42. doi: 10.1203/00006450-197604000-00008.
7
Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.
J Clin Microbiol. 1980 Sep;12(3):426-32. doi: 10.1128/jcm.12.3.426-432.1980.
8
Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2).
Virology. 1975 Aug;66(2):522-32. doi: 10.1016/0042-6822(75)90224-x.
9
Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adults.
J Infect Dis. 1977 Aug;136(2):256-62. doi: 10.1093/infdis/136.2.256.
10
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01579-17. Print 2017 Dec 1.
引用本文的文献
1
Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.
PLoS Pathog. 2018 Feb 15;14(2):e1006770. doi: 10.1371/journal.ppat.1006770. eCollection 2018 Feb.
2
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.
Virology. 2012 Nov 25;433(2):320-8. doi: 10.1016/j.virol.2012.08.027. Epub 2012 Sep 7.
3
Identification of a natural human serotype 3 parainfluenza virus.
Virol J. 2011 Feb 9;8:58. doi: 10.1186/1743-422X-8-58.
4
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.
Vaccine. 2010 Mar 24;28(15):2788-98. doi: 10.1016/j.vaccine.2010.01.050. Epub 2010 Feb 20.
5
Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation.
Antivir Ther. 2009;14(7):891-8. doi: 10.3851/IMP1420.
6
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates.
Vaccine. 2010 Jan 8;28(3):767-79. doi: 10.1016/j.vaccine.2009.10.069. Epub 2009 Oct 24.
7
Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.
Antimicrob Agents Chemother. 2009 Sep;53(9):3942-51. doi: 10.1128/AAC.00220-09. Epub 2009 Jun 29.
8
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17.
9
Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates.
J Virol. 2008 Sep;82(18):8965-77. doi: 10.1128/JVI.00853-08. Epub 2008 Jul 9.
10
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.
J Virol. 2008 Aug;82(16):8059-70. doi: 10.1128/JVI.02263-07. Epub 2008 Jun 4.
本文引用的文献
1
Failure of naturally acquired rhinovirus infections to produce temporal immunity to heterologous serotypes.
Infect Immun. 1974 Nov;10(5):1192-3. doi: 10.1128/iai.10.5.1192-1193.1974.
2
The influence of certain salts, amino acids, sugars, and proteins on the stability of rickettsiae.
J Bacteriol. 1950 Apr;59(4):509-22. doi: 10.1128/jb.59.4.509-522.1950.
3
Interference phenomena between animal viruses; a review.
J Immunol. 1950 Mar;64(3):203-36.
4
THE USE OF VOLUNTEERS IN MEDICAL VIROLOGY.
Prog Med Virol. 1964;6:1-26.
5
STUDIES WITH RHINOVIRUSES IN VOLUNTEERS: PRODUCTION OF ILLNESS, EFFECT OF NATURALLLY ACQUIRED ANTIBODY, AND DEMONSTRATION OF A PROTECTIVE EFFECT NOT ASSOCIATED WITH SERUM ANTIBODY.
J Clin Invest. 1964 Jan;43(1):56-67. doi: 10.1172/JCI104894.
6
Infection of human volunteers with type 2 hemadsorption virus.
Science. 1958 Oct 3;128(3327):779-80. doi: 10.1126/science.128.3327.779.
7
Interferon in mice: protection against small doses of virus.
J Gen Virol. 1967 Jul;1(3):395-7. doi: 10.1099/0022-1317-1-3-395.
8
A statewide mass measles immunization program.
JAMA. 1967 Feb 27;199(9):619-23.
9
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus.
J Infect Dis. 1973 Oct;128(4):488-93. doi: 10.1093/infdis/128.4.488.
10
Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man.
J Infect Dis. 1973 Oct;128(4):479-87. doi: 10.1093/infdis/128.4.479.
Zotero 插件